Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Roundworm found in raw fish inspires cancer test
Sushi
A roundworm which can be found in raw fish such as Sushi can accurately detect cancer.

Roundworms successfully identify cancer in nine forms of the disease

A free-living roundworm that may be picked up by eating raw fish can detect cancer in people's urine, according to a study published in Plos One.

Researchers in Japan have found that Caenorhabditis elegans worms can accurately sniff-out cancer in the urine of patients with various forms of the disease, including stomach, breast and lung cancer.

They are now working with technology companies Johnan and Hitachi to turn the finding into a diagnostic test that can be used to diagnose the disease in its early stages.

Takaaki Hirotsu from Kyushu University, who co-led the work, said: "In existing tests, people must have different examinations according to the type of cancer they have. Our odour based-test detected all nine types of cancer we tested."

The researchers decided to investigate the cancer detecting ability of roundworms after encountering a 63-year old man with Anisakis larvae in his digestive system. 
The worms had attached themselves to a small lesion in the man's stomach, which turned out to be the early stages of gastric cancer.

To find out whether the odour of the cancer lesion was attracting the roundworms, the researchers added drops of culture medium that cancer cells had grown in on one side of petri dishes.  On the opposite side they put drops of fresh culture medium. When they added C. elegans to the dishes, the worms moved towards the cancer medium.

Other kinds of cells were also grown in the medium, but the worms were not attracted to these. The researchers also took out the olfactory sense neurones in some of the worms, which stopped them moving towards the cancer side of the dish, suggesting that they are attracted by smell.

When placed nearby spots of urine from people with and without cancer, the worms were only attracted to the sample of the people with cancer.  Out of 242 samples, 24 of which had a cancer diagnosis, the worms correctly identified cancer 96 per cent of the time. The researchers say that this success rate is better than any blood test.

Out of 242 samples, 24 of which had a cancer diagnosis, the worms correctly identified cancer 96 per cent of the time - a success rate which is better than any blood test, the researchers say.

The worms successfully identified cancer in all nine forms of the disease they were exposed to - stomach, colorectal colon, oesophageal, pancreas, bile duct, prostate, breast and lung cancer.

The team are now looking to see whether different forms of cancer release different odours, and whether this has an effect in the worms.
It is hoped that a commercial product will be ready by 2019.

Image (C) Mrmcdonnell

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.